Olopatadine Hydrochloride (Apotex Corp.)
Welcome to the PulseAid listing for the Olopatadine Hydrochloride drug offered from Apotex Corp.. This Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Apotex Corp. |
| NON-PROPRIETARY NAME: | olopatadine hydrochloride |
| SUBSTANCE NAME: | OLOPATADINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] |
| ROUTE: | NASAL |
| DOSAGE FORM: | SPRAY, METERED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2014-10-27 |
| END MARKETING DATE: | 0000-00-00 |
Olopatadine Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Olopatadine Hydrochloride from Apotex Corp. |
| LABELER NAME: | Apotex Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 665(ug/1) |
| START MARKETING DATE: | 2014-10-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 60505-0845_255fefaa-5e06-2a06-600d-2dbf6e11ac2c |
| PRODUCT NDC: | 60505-0845 |
| APPLICATION NUMBER: | ANDA091572 |
Other OLOPATADINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
